Leriglitazone

Leriglitazone
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T15736-1mg 1 mg

7 - 10 business days*

651.00€
TGM-T15736-5mg 5 mg

7 - 10 business days*

1,877.00€
 
Description: Leriglitazone, a metabolite of pioglitazone, binds to the PPARgamma C-terminal... more
Product information "Leriglitazone"
Description: Leriglitazone, a metabolite of pioglitazone, binds to the PPARgamma C-terminal ligand-binding domain (Ki: 1.2 µM) and induces transcriptional efficacy of the PPARgamma (EC50: 680 nM). Leriglitazone PioOH is a PPARgamma agonist, stabilizes the PPARgamma activation function-2 (AF-2) co-activator binding surface. Target: Others. Smiles: O=C1SC(C(=O)N1)CC2=CC=C(OCCC3=NC=C(C=C3)C(O)C)C=C2. References: Mosure SA,et al. Structural Basis of Altered Potency and Efficacy Displayed by a Major in Vivo Metabolite of the Antidiabetic PPARgamma Drug Pioglitazone. J Med Chem. 2019 Feb 28,62(4):2008-2023.
Keywords: Hydroxypioglitazone
Supplier: TargetMol
Supplier-Nr: T15736

Properties

Application: Targets peroxisome proliferator-activated receptor gamma (NR1C3, PPARG)
MW: 372.44 D
Formula: C19H20N2O4S
Format: 32160405

Database Information

CAS : 146062-44-4| Matching products
KEGG ID : K08530 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Leriglitazone"
Write a review
or to review a product.
Viewed